iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

On 9 April 2022

image

Lupin said that it has received approval from the United States Food and Drug Administration (FDA) for Vigabatrin for oral solution USP.

image

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to market Colestipol hydrochloride tablets.

image

On 23 March 2022

image

Indias industrial production index rose 1.3 percent year-on-year in January, preliminary data from the statistics ministry showed Friday. In the same month last year, output shrank 0.6 percent. The December growth was revised to 0.7 percent from 0.4 percent. In January, manufacturing grew 1.1 percent year-on-year, mining production rose 2.8 percent and electricity output increased 0.9 percent. In the April to January period, industrial production […]

image

WAMIL’s facilities at Telangana have installed a capacity of 17,729 MTPA of Spunlace with estimated revenue of Rs370 crore per annum at around full capacity utilization.

image

ISMT announced that the company has remitted the full and final settlement amount, towards the outstanding debt of the Company, to the respective Lenders/ Authorized Dealers. Powered by Capital Market – Live News

image

On 21 March 2022

image

Equity indices traded higher with decent gains in early trade. The Nifty traded near the 16,700 mark. Banking and financial stocks saw buying demand while auto and FMCG shares came under selling pressure. At 9:20 IST, the barometer index, the S&P BSE Sensex, rose 169.62 points or 0.31% at 55,719.15. The Nifty 50 index gained 41.65 points or 0.25% at 16,672.90. In the broader market, […]

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.